Direkt zum Inhalt
Merck
  • Experimental study of the impact of antimicrobial treatments on Campylobacter, Enterococcus and PCR-capillary electrophoresis single-strand conformation polymorphism profiles of the gut microbiota of chickens.

Experimental study of the impact of antimicrobial treatments on Campylobacter, Enterococcus and PCR-capillary electrophoresis single-strand conformation polymorphism profiles of the gut microbiota of chickens.

Journal of medical microbiology (2014-08-22)
Gwenaëlle Mourand, Eric Jouy, Stéphanie Bougeard, Alexandra Dheilly, Annaëlle Kérouanton, Salman Zeitouni, Isabelle Kempf
ZUSAMMENFASSUNG

An experiment was conducted to compare the impact of antimicrobial treatments on the susceptibility of Campylobacter, Enterococcus faecium and Enterococcus faecalis, and on the diversity of broiler microbiota. Specific-pathogen-free chickens were first orally inoculated with strains of Campylobacter and Enterococcus faecium. Birds were then orally treated with recommended doses of oxytetracycline, sulfadimethoxine/trimethoprim, amoxicillin or enrofloxacin. Faecal samples were collected before, during and after antimicrobial treatment. The susceptibility of Campylobacter, Enterococcus faecium and Enterococcus faecalis strains isolated on supplemented or non-supplemented media was studied and PCR-capillary electrophoresis single-strand conformation polymorphism (CE-SSCP) profiles of the gut microbiota were analysed. Enrofloxacin-resistant Campylobacter were selected in the enrofloxacin-treated group and showed the Thr86Ile mutation in the gyrA gene. Acquisition of the tetO gene in Campylobacter coli isolates was significantly more frequent in birds given oxytetracycline. No impact of amoxicillin treatment on the susceptibility of Campylobacter could be detected. Ampicillin- and sulfadimethoxine/trimethoprim-resistant Enterococcus faecium were selected in amoxicillin-treated broilers, but no selection of the inoculated vancomycin-resistant Enterococcus faecium could be detected, although it was also resistant to tetracycline and sulfadimethoxine/trimethoprim. PCR-CE-SSCP revealed significant variations in a few peaks in treated birds as compared with non-treated chickens. In conclusion, antimicrobial treatments perturbed chicken gut microbiota, and certain antimicrobial treatments selected or co-selected resistant strains of Campylobacter and Enterococcus.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Glycerin, ACS reagent, ≥99.5%
Sigma-Aldrich
Glycerin, Molecular Biology, ≥99.0%
Sigma-Aldrich
Glycerin, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
Glycerin, ≥99.5%
Sigma-Aldrich
Glycerin -Lösung, 83.5-89.5% (T)
Sigma-Aldrich
Glycerin, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
Sigma-Aldrich
Glycerin, BioUltra, Molecular Biology, anhydrous, ≥99.5% (GC)
Supelco
Glycerin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Trimethoprim, ≥98.5%
Sigma-Aldrich
Glycerin, BioXtra, ≥99% (GC)
Sigma-Aldrich
Amoxicillin, 95.0-102.0% anhydrous basis
USP
Glycerin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Glycerin, FCC, FG
Sigma-Aldrich
Glycerin, meets USP testing specifications
Sigma-Aldrich
Trimethoprim, ≥99.0% (HPLC)
Sigma-Aldrich
1,1,2,2-Tetrabromethan, purum p.a., for separation of mineral compounds, ≥98.0% (GC)
Sigma-Aldrich
Esculin Hydrat, ≥98%
USP
Amoxicillin, United States Pharmacopeia (USP) Reference Standard
Supelco
Glycerin, analytical standard
Supelco
Trimethoprim, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
1,1,2,2-Tetrabromethan, 98%
Sigma-Aldrich
Enrofloxacin, ≥99.0%
Supelco
Enrofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Oxytetracyclin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Enrofloxacin, VETRANAL®, analytical standard
Sigma-Aldrich
Glycerin, tested according to Ph. Eur., anhydrous
Supelco
Trimethoprim, VETRANAL®, analytical standard
Sigma-Aldrich
Esculin Hydrat, ≥98.0% (HPLC)
USP
Oxytetracyclin, United States Pharmacopeia (USP) Reference Standard
Millipore
Oxytetra-Selektivzusatz, suitable for microbiology